Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imaging

Keyphrases

• All-cause Mortality 14%
• Autoantibodies 100%
• Autoantibody Biomarker 14%
• Biomarker Testing 14%
• Blood Test 100%
• Blood-based 14%
• Cancer Comorbidity 14%
• Cancer Mortality 14%
• Cancer Occurrence 14%
• Cancer Staging 14%
• Clinical Care 28%
• Clinical Practice 14%
• Computed Tomography 28%
• Computed Tomography Screening 14%
• Control Arm 28%
• Early Lung Cancer Diagnosis 100%
• Early-stage Lung Cancer 14%
• Emerging Standards 14%
• Hazard Ratio 14%
• High Risk 14%
• High Specificity 14%
• Low-dose Computed Tomography 28%
• Lung 100%
• Lung Cancer 71%
• Lung Cancer Risk 28%
• Lung Cancer Screening 14%
• Post-randomization 14%
• Randomized Controlled Trial 14%
• Randomized Trial 100%
• Scotland 28%
• Stage III-IV 42%
• Stage Shift 14%
• Symptom Presentation 14%
• Working Diagnosis 14%

Medicine and Dentistry

• All Cause Mortality 10%
• Arm 40%
• Autoantibodies 100%
• Biological Marker 20%
• Cancer Diagnosis 10%
• Cancer Risk 10%
• Cancer Staging 10%
• Computer Assisted Tomography 40%
• Early Diagnosis 100%
• Hazard Ratio 10%
• Low Drug Dose 20%
• Lung Cancer 100%
• Malignant Neoplasm 10%
• Population Research 10%
• Randomized Controlled Trial 10%

Pharmacology, Toxicology and Pharmaceutical Science

• All Cause Mortality 10%
• Autoantibodies 100%
• Biological Marker 20%
• Cancer Staging 10%
• Comorbidity 10%
• Lung Cancer 100%
• Malignant Neoplasm 10%
• Phase IV 10%
• Population Study 10%
• Randomized Controlled Trial 10%